Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 671

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 671
---
 and received by Kineta subsequent to December 31, 2024, to illustrate the funding provided by TuHURA
which, under the terms of the Merger Agreement, allows for all such loaned amounts between the parties to be credited against the cash component of the Merger Consideration to be paid to Kineta stockholders in the Mergers (refer to Adjustment
E).

CRelating to the Mergers, to record proceeds received of $18,400,000 after taking into account $1,600,000 (comprised of
an estimated $1,200,000 of placement fees and an additional $400,000 in legal fees), following the issuance, through a Concurrent Investment to be consummated prior to the Closing of the Mergers, of approximately 4,952,579 shares of TuHURA Common
Stock at an estimated price of the TuHURA 10-day VWAP as of the date each investor subscribes to the Concurrent Investment, approximately $4.0383 per share (based on the VWAP as of April 30, 2025). To-date, while TuHURA has not currently executed any subscription agreement in connection with this contemplated Concurrent Investment, this pro forma adjustment is reflected in the unaudited pro forma condensed
combined financial information as contemplated since it is a condition precedent to the closing of the Mergers.

D Reflects the
actual and assumed exercises of outstanding TuHURA warrants and Penny Warrants subsequent to December 31, 2024 for a total underlying of 1,653,666 shares issued (consisting of 1,356,637 and 297,029 warrants exercised, respectively). While the
subsequent exercises are not directly attributable to the closing of the Mergers, since the subsequent issuance of shares of TuHURA Common Stock directly impacts the share capitalization of the combined company on a pro forma basis, a pro forma
adjustment of 1,653 is presented to recognize the shares of TuHURA Common Stock issued at par value and give pro forma effect to the Mergers as if all the related transactions occurred on December 31, 2024.

TuHURA initially recorded a Warrant Note Receivable of $3,057,904 for the value of the warrants, including interest, that the holders of the
warrants issued in lieu of payment upon exercise. Based on the terms and provisions of these notes, the entire amount is expected to be received prior to the Closing Date